Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publication section wording updated to clarify auto-population from PubMed and potential non-relations to the study. Page revision tag updated to Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T07:30:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page no longer displays the generic government funding status notice. This change does not affect the study details, eligibility criteria, or results information.
    Difference
    0.1%
    Check dated 2025-11-19T08:21:36.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    In the Taiwan location entry, 'Tainan City, Taiwan, 70457' was changed to 'Tainan, Taiwan, 70457'.
    Difference
    0.0%
    Check dated 2025-11-12T00:17:36.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT03302234; the content appears unchanged between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:17:19.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    1%
    Check dated 2025-10-06T16:00:21.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Updated to v3.1.0 and removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a narrowing of content coverage. The page now reflects the new revision but loses these topics.
    Difference
    0.2%
    Check dated 2025-09-29T09:56:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.